Should we apply?
Development of Biomarkers or Composite Biomarkers for Neurological and Neuromuscular Disorders (R61/R33 - Clinical Trial Optional). Grant professionals check the deal-breakers before writing anything, then ask whether it's worth the effort. Answers GrantMe already knows are filled in. Change any that are wrong.